News and Events
Workshop on ADC Chemistry at World ADC 2020 in London, UK
NJ Bio would like to share that Dr. Naresh Jain, NJ Bio’s President & CEO, and Dr. Jagath Reddy Junutula, Senior VP Research & Development at ModMab Therapeutics and member of NJ Bio’s Scientific Advisory Board, will hold a Workshop at the 10th Annual World...
NJ Bio’s President & CEO, Dr. Naresh Jain, has received UAA-ICT’s Distinguished Alumnus Award
Dr. Naresh Jain, NJ Bio’s President & CEO, has been presented with this year’s UAA-ICT Distinguished Alumnus Award in the Research Category by the UDCT Alumni Association (UAA). This prestigious award, given out annually in five categories, was awarded to Dr. Jain...
NJ Bio expands leadership team with addition of Dr. Srinath Thirumalairajan
NJ Bio is glad to announce that Dr. Srinath (Sri) Thirumalairajan has joined the company as Executive Director of Bioconjugation Chemistry and cGMP Manufacturing. Sri is an experienced Synthetic Organic/Medicinal Chemist with more than a dozen years of industrial...
Dr. Jagath R. Junutula and Dr. Zhihua Sui have joined NJ Bio’s Scientific Advisory Board
NJ Bio is pleased to announce that Dr. Jagath Reddy Junutula and Dr Zhihua Sui two well-known and esteemed industry experts in oncology drug discovery (including ADCs) and medicinal chemistry/drug discovery, respectively, have joined NJ Bio’s Scientific Advisory Board...
World ADC San Diego 2019
NJ Bio will exhibit at the 10th annual World ADC 2019 in San Diego, CA, from October 10 – 11, 2019. World ADC, organized by Hanson Wade, is the longest standing and most comprehensive antibody-drug conjugate meeting. Please visit us at our booth to discuss...
Dr. Naresh Jain, President & CEO of NJ Bio, to speak at World ADC 2019
Dr. Naresh Jain, President & CEO of NJ Bio, will speak of Friday, October 11, 2019, at 9:10 am at World ADC 2019 in San Diego. The topic of Dr. Jain’s talk will be “Protoxins: The Next Generation of Toxins for Antibody-Drug Conjugates.” The presentation will cover...
Philadelphia Regional Integrated Medicine Alliance
Philadelphia Regional Integrated Medicine Alliance (“PRIMA”) NJ Biop has joined the Greater Philadelphia Regional Integrated Medicine Alliance (PRIMA). PRIMA is a regional, integrated and virtual public/private partnership focused exclusively on nurturing the region’s...
BIO International Convention 2019
NJ Bio will exhibit at The BIO International Convention (BIO) in Philadelphia, PA, from June 4 – 6, 2019. This convention attracts more than 16,000 biotechnology and pharma leaders and brings together a wide spectrum of life science and application areas including...